Immunology and Microbiology
Hepatitis C Virus
100%
Hepatitis C
59%
COVID-19
45%
Severe Acute Respiratory Syndrome Coronavirus 2
41%
Vaccine Efficacy
39%
T Cell
33%
Neutralizing Antibody
29%
Human Immunodeficiency Virus
28%
Monospecific Antibody
25%
Blood Plasma
18%
Epitope
18%
Transplant Procedure
17%
interferon
17%
Antibody Response
17%
Vaccination Policy
14%
Immune Response
14%
Omicron Coronavirus Variant
13%
Viral Clearance
13%
Interleukin 18
13%
Neutralization
12%
Humoral Immunity
11%
Virus Vaccine
11%
Viremia
11%
Spike
10%
Human Immunodeficiency Virus 1
9%
Cytokine
9%
Glycoprotein
9%
Titer
8%
T-Helper Cell
8%
Inflammasome
8%
Macrophage
8%
B Cell
7%
Viral Envelope
7%
Monocyte
7%
Antibody Titer
6%
Proinflammatory Cytokine
6%
Viral Replication
6%
Chemokine
6%
Single Nucleotide Polymorphism
6%
Cytotoxic T-Cell
5%
T Cell Receptor
5%
Viral Disease
5%
Adoptive Immunity
5%
Adaptive Immune System
5%
Allele
5%
Coronavirinae
5%
Prevalence
5%
Tumor Necrosis Factor
5%
Programmed Death 1 Ligand 1
5%
Keyphrases
Hepatitis C Virus
72%
Hepatitis C Virus Infection
34%
COVID-19
30%
Chronic Hepatitis C Virus Infection
18%
Spontaneous Clearance
18%
Hepatitis C
16%
Hepatitis C Vaccine
15%
Acute Infection
14%
Interleukin-18 (IL-18)
12%
Hepatitis C Virus Clearance
11%
Programmed Death-ligand 1 (PD-L1)
11%
Broadly Neutralizing Antibodies
11%
Solid Organ Transplant Recipients
11%
Antibody Response
10%
Epitope
10%
People Who Inject Drugs
10%
Interferon lambda (IFN-λ)
10%
Immune Response
9%
Vaccination
9%
Neutralizing Antibodies
9%
Vaccine Development
9%
AIDS/HIV
9%
Hepatitis C Virus RNA
8%
Genotype
8%
Confidence Interval
7%
T Cell Response
7%
Virus
7%
Viral Persistence
7%
Fine Mapping
6%
Multi-ancestry
6%
Multisystem Inflammatory Syndrome in children (MIS-C)
6%
Severe Coronavirus Disease 2019
6%
People Living with HIV (PLHIV)
6%
MRNA Level
6%
Virus Persistence
6%
Viremia
5%
Acute Phase
5%
Cellular Immune Response
5%
Chemokines
5%
Cell-free DNA (cfDNA)
5%
Interferon-α (IFN-α)
5%
Tumor Necrosis Factor-α
5%
Omicron Variant
5%
Medicine and Dentistry
COVID-19
44%
Severe Acute Respiratory Syndrome Coronavirus 2
32%
Infection
19%
Hepatitis C Virus
19%
Disease
13%
Hepatitis C
13%
Human Immunodeficiency Virus
12%
Outpatient
8%
Transplantation
7%
Serositis
7%
Cytokine
5%
Neutralization
5%
Immune Response
5%
Interferon
5%
Symptom
5%
T Cell
5%
